16
Participants
Start Date
April 25, 2016
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
BMS-986141
Aspirin
Placebo
York Hospital, York
Hospital of the University of Pennsylvania, Philadelphia
Local Institution, Newark
Local Institution, Baltimore
West Virginia University, Morgantown
Guilford Medical Associates, Pa, Greensboro
Local Institution, Chapel Hill
Duke University Medical Center, Durham
Medical University Of South Carolina, Charleston
University Of Florida Hsc/Jacksonville, Jacksonville
University Of Florida, Gainesville
Florida Hospital, Orlando
Intercoastal Medical Group, Sarasota
Local Institution, Memphis
University Of Louisville, Louisville
Advanced Neurology Specialists, Great Falls
Presence Saint Joseph Medical Center, Joliet
St. Lukes Marion Bloch Neuroscience Institute, Kansas City
Local Institution, Omaha
Banner University Medical Ctr, Phoenix
Hoag Memorial Hospital, Newport Beach
Providence Portland Med Ctr, Portland
Providence St Vincent Medical Center, Portland
Oregon Health Science Univ, Portland
Local Institution, Hidaka-shi
Local Institution, Nagoya
Local Institution, Kobe
Tufts Medical Center, Boston
Boston Medical Center, Boston
JFK Medical Center, Edison
Local Institution, Sapporo
Local Institution, Sendai
Local Institution, Fukuoka
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY